Georgia Long Term Care And Consulting - Medicare Primary Care in Tucker, GA

Georgia Long Term Care And Consulting is a medicare enrolled primary clinic (Family Medicine) in Tucker, Georgia. The current practice location for Georgia Long Term Care And Consulting is 1990 Lakeside Pkwy, Suite 170, Tucker, Georgia. For appointments, you can reach them via phone at (770) 938-1757. The mailing address for Georgia Long Term Care And Consulting is Po Box 13003, Atlanta, Georgia and phone number is (770) 938-1757.

Georgia Long Term Care And Consulting is licensed to practice in Georgia (license number 051042). The clinic also participates in the medicare program and its NPI number is 1073562922. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (770) 938-1757.

Contact Information

Georgia Long Term Care And Consulting
1990 Lakeside Pkwy
Suite 170
Tucker
GA 30084-5884
(770) 938-1757
(770) 938-1759

Primary Care Clinic Profile

Full NameGeorgia Long Term Care And Consulting
SpecialityFamily Medicine
Location1990 Lakeside Pkwy, Tucker, Georgia
Authorized Official Name and PositionTerence Andrew Frinks (PRESIDENT/CEO)
Authorized Official Contact7709381757
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Georgia Long Term Care And Consulting
Po Box 13003
Atlanta
GA 30324-0003

Ph: (770) 938-1757
Georgia Long Term Care And Consulting
1990 Lakeside Pkwy
Suite 170
Tucker
GA 30084-5884

Ph: (770) 938-1757

NPI Details:

NPI Number1073562922
Provider Enumeration Date05/09/2006
Last Update Date08/22/2020

Medicare PECOS Information:

Medicare PECOS PAC ID3678589967
Medicare Enrollment IDO20060223000402

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Medical Identifiers

Medical identifiers for Georgia Long Term Care And Consulting such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1073562922NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine 051042 (Georgia)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Georgia Long Term Care And Consulting acts as a billing entity for following providers:
Provider NameTessa V Thompson
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1245385053
PECOS PAC ID: 0042112658
Enrollment ID: I20040123000688

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameDiana Margaret Whiteman
Provider TypePractitioner - Physical Medicine And Rehabilitation
Provider IdentifiersNPI Number: 1366490419
PECOS PAC ID: 6002719200
Enrollment ID: I20040127000713

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameJames Rogan
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1982704300
PECOS PAC ID: 5597740217
Enrollment ID: I20040618000574

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameTerence Frinks
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1285761833
PECOS PAC ID: 7719947423
Enrollment ID: I20041018000347

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NamePatrick Antoine
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1427022904
PECOS PAC ID: 1850289695
Enrollment ID: I20051215000060

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameRhonda D White
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1922096510
PECOS PAC ID: 2365457843
Enrollment ID: I20060221000247

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameLuella C Wheeler Ikuesan
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1881611663
PECOS PAC ID: 4385653088
Enrollment ID: I20060407000152

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameChae Lee
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1518916998
PECOS PAC ID: 7416968623
Enrollment ID: I20060531000073

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameMollie C Headrick
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1336286723
PECOS PAC ID: 6002912284
Enrollment ID: I20070504000060

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameEugene H Harris
Provider TypePractitioner - Emergency Medicine
Provider IdentifiersNPI Number: 1235344367
PECOS PAC ID: 2062513443
Enrollment ID: I20070730000481

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameEric A Benning
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1932196755
PECOS PAC ID: 5092892455
Enrollment ID: I20080409000375

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameLisa M Rose Cantrell
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1114053345
PECOS PAC ID: 0244318202
Enrollment ID: I20080416000560

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameAndrea Brown
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1215107875
PECOS PAC ID: 5698844355
Enrollment ID: I20080521000114

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameCharles F Scott
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1063540110
PECOS PAC ID: 2365511961
Enrollment ID: I20080522000407

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameLatonia M Addison
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1962429605
PECOS PAC ID: 4789684424
Enrollment ID: I20100331000273

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameCarla Yvonne Bedford Dixon
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1801849716
PECOS PAC ID: 4385608363
Enrollment ID: I20100428000282

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameCheryl Elizabeth Willingham
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1548587264
PECOS PAC ID: 7911037403
Enrollment ID: I20100609000842

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameEvon R Robinson
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1538355078
PECOS PAC ID: 7113016908
Enrollment ID: I20100719000693

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameRoseline A Makinde
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1902108491
PECOS PAC ID: 5193904506
Enrollment ID: I20110131000831

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameSusanna C Hammontree
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1164783080
PECOS PAC ID: 4385891183
Enrollment ID: I20120830000208

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameSongeun Choi
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1194076539
PECOS PAC ID: 0749435154
Enrollment ID: I20130308000176

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameDeshawnda N Garnett
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1417373531
PECOS PAC ID: 8628291903
Enrollment ID: I20140514002357

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameDenise Tracy
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1013336759
PECOS PAC ID: 0244450872
Enrollment ID: I20141002002370

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameQumara Hill-smith
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1871906024
PECOS PAC ID: 5597987594
Enrollment ID: I20141106001255

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameUrielle Joseph
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1679976799
PECOS PAC ID: 1052633112
Enrollment ID: I20141201001811

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameMillicent L Brown
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1407994940
PECOS PAC ID: 3971541913
Enrollment ID: I20141219000694

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameTricia Salmon-anderson
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1194120956
PECOS PAC ID: 0547588634
Enrollment ID: I20150422000803

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameKimberly R Fitzgerald
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1558765974
PECOS PAC ID: 8628397304
Enrollment ID: I20150430001082

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameMariana Sirbu
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1629445192
PECOS PAC ID: 0244540466
Enrollment ID: I20151030000297

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameTracy L Bennett
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1811379332
PECOS PAC ID: 4183934045
Enrollment ID: I20151104001817

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameAma Browne
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1205207966
PECOS PAC ID: 5395055065
Enrollment ID: I20151109001805

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameThandeka T Ntuli
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1386003986
PECOS PAC ID: 4789973942
Enrollment ID: I20160511002805

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameJeysirine S Telesford
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1265897540
PECOS PAC ID: 6204114135
Enrollment ID: I20161028000169

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameMarie Nozil
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1164972188
PECOS PAC ID: 4688954886
Enrollment ID: I20161205002305

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameSabine Doirin
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1265982284
PECOS PAC ID: 8921388133
Enrollment ID: I20161205002415

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameOneika N Rigby-britton
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1295130763
PECOS PAC ID: 3779865696
Enrollment ID: I20170127002434

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameAblavi A Agomessou
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1164885778
PECOS PAC ID: 4385926112
Enrollment ID: I20170131000635

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameRebecca M Scruggs
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1356893432
PECOS PAC ID: 5496948259
Enrollment ID: I20170222001470

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameSimone Anderson
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1184176356
PECOS PAC ID: 9739464777
Enrollment ID: I20170314001184

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameDaphne Ray-leverett
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1700251428
PECOS PAC ID: 9830476522
Enrollment ID: I20170505001750

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameCharlot Guens Louis
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1558816579
PECOS PAC ID: 9032494299
Enrollment ID: I20171102003358

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameTraci Robinson
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1659871994
PECOS PAC ID: 0840554101
Enrollment ID: I20180514001991

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameMichael U Okenchi
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1013482553
PECOS PAC ID: 1153675012
Enrollment ID: I20181112001373

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameAminat Babalola
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1891270443
PECOS PAC ID: 2466796131
Enrollment ID: I20181206001596

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameJanice A Scott
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1376028639
PECOS PAC ID: 2769727981
Enrollment ID: I20181217001647

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameYolette Lafontant
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1205316395
PECOS PAC ID: 9436492568
Enrollment ID: I20190513002466

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameTerrell M Bond
Provider TypePractitioner - General Practice
Provider IdentifiersNPI Number: 1336177583
PECOS PAC ID: 4486750205
Enrollment ID: I20190729002641

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NamePearl Amoako
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1013482975
PECOS PAC ID: 3678804804
Enrollment ID: I20191018001797

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameYvanne Jean-obei
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1417503889
PECOS PAC ID: 0547693541
Enrollment ID: I20191205000985

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameToni Marie Green
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1821457615
PECOS PAC ID: 4284923285
Enrollment ID: I20191217000861

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameChristiana Ojongnfong
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1225683626
PECOS PAC ID: 4183058647
Enrollment ID: I20191217001055

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameInoka A Devapriya
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1629463864
PECOS PAC ID: 4183927346
Enrollment ID: I20191230002302

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameSohna Florence
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1134770407
PECOS PAC ID: 7214361872
Enrollment ID: I20200107002514

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameYvona W Butts
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1144834284
PECOS PAC ID: 8325459381
Enrollment ID: I20201123001750

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameTemeka L Johnson
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1316518475
PECOS PAC ID: 0143493999
Enrollment ID: I20220523001857

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameLiliya Kyrychenko
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1124766282
PECOS PAC ID: 4284014507
Enrollment ID: I20220705001606

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameElma O Okogba
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1669017273
PECOS PAC ID: 0244614717
Enrollment ID: I20220901000463

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameCelia S Ivery
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1508538216
PECOS PAC ID: 9436533726
Enrollment ID: I20220906002383

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameMichael O Pompey
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1972805315
PECOS PAC ID: 9133591183
Enrollment ID: I20230221001192

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

Provider NameAlicia Bell
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1205536752
PECOS PAC ID: 4789041245
Enrollment ID: I20230530000211

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 4 days ago

News Archive

Repeated testing produces 'practice effect' that obscures true cognitive decline

Alzheimer's disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak.

Surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software

German cancer surgeons have, for the first time, successfully removed a tumour with the aid of new 3-D computer modelling software which the designers say will make these operations safer and more accurate.

Study: CCSVI may result from multiple sclerosis progression

A just released study on the relationship between multiple sclerosis and chronic cerebral venous insufficiency, a narrowing of the extracranial veins that restricts the normal outflow of blood from the brain, found that CCSVI may be a result of MS, not a cause.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more News

› Verified 4 days ago


Family Medicine in Tucker, GA

Meadows Med Group Inc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 4426 Hugh Howell Rd, Ste 429, Tucker, GA 30084
Phone: 404-667-9648    
N.d. Lien, P.c.
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 4865 Lavista Rd, Suite A, Tucker, GA 30084
Phone: 770-270-0290    Fax: 770-723-0598
Focus Care Medical Center
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 2171 Northlake Pkwy, Tucker, GA 30084
Phone: 770-559-1523    
Medical Associates Of Georgia
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1462 Montreal Rd, 307, Tucker, GA 30084
Phone: 770-938-5552    Fax: 678-395-7702
Providence Pediatrics, Llc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 2171 Northlake Pkwy, Suite 114, Tucker, GA 30084
Phone: 770-939-7477    Fax: 770-939-7750
Executive Medical Associates P.c.
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 4426 Hugh Howell Rd, Suite B303, Tucker, GA 30084
Phone: 770-572-7574    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.